The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada, Vishakapatnam, on November 09, 2018. The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new product. The company will be submitting a detailed … Read more
Dr. Reddy’s Laboratories has launched Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA). The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ending in August 2018 according … Read more
Dr. Reddy’s Laboratories has reported results for second quarter ended September 30, 2018. The company has reported over 3 fold jump in its net profit at Rs 346.20 crore for the quarter under review as compared to Rs 100.70 crore for the same quarter in the previous year. Total income of the company increased by … Read more
Dr. Reddy’s Laboratories has received an approval for Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the US Food and Drug Administration (USFDA). The company is working towards launching the product. The Aggrenox brand and generic had US sales of … Read more
Dr. Reddy’s Laboratories has entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla in Hyderabad, to Therapiva an emerging generics pharmaceutical company. This divestiture is being done by way of slump sale (as a going concern) and includes all related fixed assets (land and building), current assets, … Read more
Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCI) Tablets in the United States market approved by the US Food and Drug Administration (USFDA). The WELCHOL brand and generic had US sales of around $471 million MAT for the most recent twelve months ending in August … Read more
Men’s doubles match witnessed a brilliant comeback from Manu and Sumeeth against compatriots Arjun MR and Ramchandran Shlok in the 51-minute quarter-final. After going down 17-21 in the opening game, Manu and Sumeeth kept their nerves to win the second game with a 21-19 margin before fending off the opponents in the decider with a … Read more
